Erlotinib As Maintenance Treatment In Advanced Non-small-cell Lung Cancer: A Multicentre, Randomised, Placebo-controlled Phase 3 Study
Federico Cappuzzo, Tudor Ciuleanu, Lilia Stelmakh, Saulius Cicenas, Aleksandra Szczésna, Erzsébet Juhász, Emilio Esteban, Olivier Molinier, Wolfram Brugger, Ivan Melezínek, Gaëlle Klingelschmitt, Barbara Klughammer, Giuseppe Giaccone
Twitter
Facebook
LinkedIn
Email